🚨 $CVM CEL-SCI Advances Multikine Toward Confirmatory Registration Study in Head & Neck Cancer
CEL-SCI Corporation, trading under ticker $CVM on the NYSE American, is moving back onto the high-alert biotech watchlist as the company continues advancing its lead cancer immunotherapy candidate,...
stockonhighalert.com